NFE2L2 and cancer: Chemopreventive drugs activate Nrf2 (Fahey et al., 2002; Iida et al., 2004; Sussan et al., 2009) and pharmacological stimulation of Nrf2 has been extensively supported as a primary method for cancer and other illness prevention (Kwak et al., 2004; Zhang et al., 2004).